Literature DB >> 463874

Drug utilization and reported adverse reactions in hospitalized children.

A A Mitchell, P Goldman, S Shapiro, D Slone.   

Abstract

An intensive drug surveillance program has been developed to study the clinical effects of drugs in hospitalized children. This program collects information on drug exposures and the occurrence of adverse clinical events. The 1669 children monitored to date received an average of 7.6 drugs during an average hospital stay of 8.4 days. A group of specified adverse clinical events, whether or not drug attributed, occurred in 45.7% of the patients; drug-attributed events (adverse drug reactions) occurred in 16.8%. Both drug use and reported adverse reactions tended to increase with age, except that newborns received many drugs but had the lowest reported adverse reaction rates. Newborns, however, had the highest rate of adverse events not attributed to drugs, suggesting that perhaps some of these latter events include presently unrecognized adverse drug reactions.

Entities:  

Mesh:

Year:  1979        PMID: 463874     DOI: 10.1093/oxfordjournals.aje.a112804

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  12 in total

1.  Risk factors associated with adverse drug reactions in hospitalised children: international multicentre study.

Authors:  Asia N Rashed; Ian C K Wong; Noel Cranswick; Stephen Tomlin; Wolfgang Rascher; Antje Neubert
Journal:  Eur J Clin Pharmacol       Date:  2011-12-14       Impact factor: 2.953

2.  Drug utilization by children in Tenerife Island.

Authors:  E J Sanz; J N Boada
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

3.  Adverse drug reactions in medical inpatients.

Authors:  I A Choonara; F Harris
Journal:  Arch Dis Child       Date:  1984-06       Impact factor: 3.791

4.  A prospective study of adverse drug reactions in hospitalized children.

Authors:  I Martínez-Mir; M García-López; V Palop; J M Ferrer; E Rubio; F J Morales-Olivas
Journal:  Br J Clin Pharmacol       Date:  1999-06       Impact factor: 4.335

5.  Retrospective analysis of the frequency and recognition of adverse drug reactions by means of automatically recorded laboratory signals.

Authors:  I Tegeder; M Levy; U Muth-Selbach; R Oelkers; F Neumann; H Dormann; T Azaz-Livshits; M Criegee-Rieck; H T Schneider; E Hahn; K Brune; G Geisslinger
Journal:  Br J Clin Pharmacol       Date:  1999-05       Impact factor: 4.335

Review 6.  Incidence of adverse drug reactions in paediatric in/out-patients: a systematic review and meta-analysis of prospective studies.

Authors:  P Impicciatore; I Choonara; A Clarkson; D Provasi; C Pandolfini; M Bonati
Journal:  Br J Clin Pharmacol       Date:  2001-07       Impact factor: 4.335

Review 7.  Information about adverse drug reactions reported in children: a qualitative review of empirical studies.

Authors:  Lise Aagaard; Arne Christensen; Ebba Holme Hansen
Journal:  Br J Clin Pharmacol       Date:  2010-10       Impact factor: 4.335

8.  Detecting adverse drug reactions on paediatric wards: intensified surveillance versus computerised screening of laboratory values.

Authors:  Steffen Haffner; Nicoletta von Laue; Stefan Wirth; Petra A Thürmann
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

9.  Off-label and unlicensed drug utilization in hospitalized children in Fortaleza, Brazil.

Authors:  Djanilson Barbosa Santos; Antonio Clavenna; Maurizio Bonati; Helena Lutescia Luna Coelho
Journal:  Eur J Clin Pharmacol       Date:  2008-08-07       Impact factor: 2.953

10.  Federal legislation and the advancement of neonatal drug studies.

Authors:  Jason R Wiles; Alexander A Vinks; Henry Akinbi
Journal:  J Pediatr       Date:  2012-10-27       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.